Stability and repeatability of a continuous twin screw granulation and drying system by Vercruysse, Jurgen et al.
 
 
biblio.ugent.be 
 
The UGent Institutional Repository is the electronic archiving and dissemination platform for all 
UGent research publications. Ghent University has implemented a mandate stipulating that all 
academic publications of UGent researchers should be deposited and archived in this repository. 
Except for items where current copyright restrictions apply, these papers are available in Open 
Access. 
 
This item is the archived peer‐reviewed author‐version of: Stability and repeatability of a 
continuous twin screw granulation and drying system 
Authors: Vercruysse J., Delaet U., Van Assche I., Cappuyns P., Arata F., Caporicci G., De Beer 
T., Remon J.P., Vervaet C. 
In: European Journal of Pharmaceutics and Biopharmaceutics, 85(3), Part B, 1031‐1038 
(2013) 
 
Optional: link to the article  
 
To refer to or to cite this work, please use the citation to the published version: 
Authors (year). Title. journal Volume(Issue)  page‐page. Doi 10.1016/j.ejpb.2013.05.002 
 Stability and repeatability of a continuous twin screw granulation and drying system 
 
J. Vercruyssea, U. Delaetb, I. Van Asscheb, P. Cappuynsc, F. Aratad, G. Caporiccid, T. De 
Beere, J.P. Remona, C. Vervaeta 
 
  
aLaboratory of Pharmaceutical Technology, Ghent University 
bDepartment of Pharmaceutical Development, Johnson&Johnson Pharmaceutical Research 
and Development, Janssen Pharmaceutica 
cGlobal Technical Services, Janssen Supply Chain, Janssen Pharmaceutica 
dGlobal Technical Services, Janssen Supply Chain, Janssen-Cilag Spa 
eLaboratory of Pharmaceutical Process Analytical Technology, Ghent University 
 
 
Corresponding Author: 
Chris Vervaet 
Ghent University 
Laboratory of Pharmaceutical Technology 
Harelbekestraat 72 
9000 Ghent 
Belgium 
Tel: +32 9 264 80 69 
Fax: +32 9 222 82 36 
E-mail: Chris.Vervaet@UGent.be 
  
Abstract 
The aim of this study was to investigate the process transfer of a commercially 
available product from the current batch fluid bed granulation and drying production method 
to an innovative continuously operating ‘from powder to tablet’ production line using twin 
screw granulation as an intermediate granulation step. By monitoring process outcomes 
(torque, water temperature at the granulator jacket inlet, differential pressure over the dryer 
filters, temperature mill screen) and granule and tablet quality in function of process time, the 
stability and repeatability during long production runs were determined. 
 
Three consecutive 5h ‘from powder to tablet’ production runs were performed using 
the ConsiGmaTM-25 system (GEA Pharma Systems, ColletteTM, Wommelgem, Belgium). A 
premix of two active ingredients, powdered cellulose, maize starch, pregelatinized starch and 
sodium starch glycolate was granulated with distilled water. After drying and milling (1000µm, 
800rpm), granules were in-line blended with magnesium stearate and directly compressed 
using a ModulTM P tablet press (tablet weight: 430 mg, main compression force: 12 kN). 
Granule (loss on drying, particle size distribution, friability, flow) and tablet (weight uniformity, 
hardness, thickness, friability, content uniformity, disintegration time and dissolution) quality 
was evaluated in function of process time. 
 
For each of the logged process outcomes, a stabilization period was needed to reach 
steady-state conditions. Slightly deviating particle size distribution and friability results for 
milled granules were observed during start-up due to initial layering of the mill screen. 
However, no deviating tablet quality was detected in function of process time.  
 
For multiple hours, granule and tablet quality was constant in function of process 
time. Furthermore, process data trends were highly repeatable. Consequently, the 
ConsiGmaTM-25 system can be considered as a stable and repeatable system for the 
continuous production of tablets via wet granulation. 
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1. Introduction 
 
Whereas most pharmaceutical manufacturing processes are currently run via 
a series of batch-wise unit-operations, continuous processing offers several 
advantages to improve the manufacturing efficiency of solid dosage forms. 
Continuous production leads to reduced costs through faster development and less 
scale-up, smaller equipment footprint and elimination of intermediate storage. 
Furthermore, online monitoring and real-time testing results in improved product 
quality. 
However, despite several advantages related to continuous production, the 
pharmaceutical industry has been slow to adopt the principle of continuous 
processing. On the one hand, high investment costs are required for the installation of 
new manufacturing equipment allowing continuous production. On the other hand, 
limited material volumes typical for the pharmaceutical industry would lead to frequent 
product changeovers on the continuous line. Additionally, pharmaceutical companies 
fear delay of product approval by the regulatory authorities. Due to high profit margins 
on their products, until recently, the economical need to change the manufacturing 
concept of pharmaceuticals was low. Currently, however, also the pharmaceutical 
industry is forced to improve the cost efficiency of their production due to the 
competition with the generics [1-4]. 
 
Although specific types of continuous wet granulators have been on the 
market for years (e.g., horizontal fluid bed granulators, multistage fluid bed, spray 
drier with integrated fluid bed, instant granulators, plough-shear mixers), none of 
these have made a significant impact within the pharmaceutical industry. On the one 
hand, this could be explained by the reluctance to move towards continuous 
processing (e.g., high profit margins, regulatory hurdles,…). On the other hand, 
equipment-related deficiencies were encountered as these techniques were only 
suitable for high material throughputs which are seldom required for pharmaceutical 
processing [3, 4]. However, equipment manufacturers have identified the specific 
needs for continuous wet granulation within the pharmaceutical industry and as a 
result a new generation of small and versatile continuous granulators has emerged, 
also suitable for manufacturing pharmaceuticals at a low production rate (10-50 kg/h).  
 
To fully benefit from the advantages offered by continuous wet granulation, the 
new techniques should be applicable to new products but also to existing products. 
Hence, it should be possible to continuously process formulations currently 
agglomerated using conventional batch-wise fluid bed or high-shear granulation into 
an end product having similar physico-chemical characteristics (hardness, friability, 
disintegration, dissolution,…). This would allow transferring existing production 
processes from a batch process using low or high shear granulators to the novel 
continuous wet granulator. Furthermore, appropriate continuous manufacturing 
techniques for solid dosage forms should allow conversion of powder into tablets in 
development, pilot, clinical and production volumes in a single compact unit and 
batch sizes should only be determined by the length of the run. Therefore, it is 
essential that the process continuously operates under steady state conditions to 
manufacture granules and tablets of a specific quality for any length of time. 
 
During the last decade, twin screw granulation as a continuous particle size 
enlargement technique has already been described by several research groups [5-10]. 
Keleb et al. evaluated the continuity of the technique over a period of 8h [5]. Recently, 
Dhenge et al. published a study on the progression of granules in different 
compartments along the length of the screws in a twin screw granulator, helping to 
provide an understanding of the twin screw granulation process [9]. 
 
The aim of the current study was to investigate the process transfer of a 
commercially available product from the actual batch fluid bed granulation and drying 
production method to an innovative continuously operating tablet manufacturing line, 
the ConsiGmaTM-system (GEA Pharma Systems, ColletteTM, Wommelgem, Belgium). 
The wet granulation module of this system consists of a high-shear twin screw 
granulator. After initial optimization work, three consecutive 5h ‘from powder to tablet’ 
production runs were performed in order to investigate the stability and repeatability 
of this system. Therefore, granule and tablet quality attributes were determined in 
function of process time. Besides, quality attributes of granules and tablets produced 
by the actual batch process and the continuous system were compared. 
 
2. Materials and methods 
 
2.1. Materials 
 
The formulation consisted of two active ingredients, powdered cellulose, maize 
starch, pregelatinized starch and sodium starch glycolate. A high-dosed slightly 
soluble API was combined with a low dosed freely soluble API. Both d50 values of the 
APIs were lower than 100 µm. Distilled water was used as granulation liquid. 
Magnesium stearate was applied as lubricant during tableting. All materials were 
delivered by Johnson&Johnson, Janssen-Cilag, Italy. 
 
2.2. Preparation of granules and tablets 
 
Granulation and drying experiments were performed using the ConsiGmaTM-
25 unit (GEA Pharma Systems, ColletteTM, Wommelgem, Belgium) (Fig. 1). This 
system consists of three modules, as already described by Chablani et al. [11] and 
Fonteyne et al. [12]: a high-shear wet granulation module, a six-segmented fluid bed 
dryer module and a granule conditioning module.  
 
The granulation module consists of a high-shear co-rotating twin screw 
granulator without die plate. The length-to-diameter ratio of the granulation unit is 
20:1. The barrel of the continuous granulator can be divided into two segments: a 
feed segment, where powder enters the barrel and consisting of conveying elements 
to transport the material through the barrel; and a work segment, where the powder is 
intensively mixed with the granulation liquid by kneading elements [12, 13]. At the 
work segment, the temperature of the barrel wall was controlled by a Pt100 
temperature sensor. As the barrel jacket was not divided into different temperature 
zones, the full length of the barrel was preheated to equal temperature (25°C). To 
evaluate the stability of the granulation process, the torque on the screws and the 
temperature of the water at the granulator jacket inlet (1 s interval) were recorded. 
The latter was monitored as changes of the temperature of the barrel wall at the work 
segment caused by friction were controlled by adapting the temperature of the water 
inside the granulator jacket (feedback control system). Both torque and water 
temperature at the granulator jacket inlet give an indication of the shear and 
compaction forces experienced by the materials inside the barrel. The equipment had 
an in-built torque gauge. The screw speed was set at 900rpm. The screw 
configuration was composed of 2 kneading zones each consisting of 4 kneading 
elements (L=D/4 for each kneading element) at an angle of 60 degrees (Fig. 2). Both 
kneading zones were separated by a conveying element (L=1.5D). An extra 
conveying element (L=1.5D) was implemented after the second kneading block 
together with 2 narrow kneading elements (L=D/6 for each kneading element) in order 
to reduce the amount of oversized agglomerates, as reported by Van Melkebeke et 
al.. During processing, a powder premix of two active ingredients, powdered cellulose, 
maize starch, pregelatinized starch and sodium starch glycolate was gravimetrically 
dosed at a feed rate of 20 kg/h by a twin screw feeder (KT20, K-Tron Soder, 
Niederlenz, Switserland). Distilled water as granulation liquid was gravimetrically 
pumped into the screw chamber using two peristaltic pumps (Watson Marlow, 
Comwall, UK) and silicon tubings (internal and external diameter of 1.6 and 6.4 mm, 
respectively) connected to 1.6 mm nozzles. Liquid was added in front of the first 
kneading element. The water concentration was equal to 13% (w/w), calculated on 
wet mass.  
 
In the ConsiGmaTM-25 unit, the granulation unit is directly connected to a six-
segmented fluid bed dryer, either horizontally or vertically. As the granulation and 
drying unit of the ConsiGmaTM-25 unit used in this study were lined up vertically, the 
wet granules were gravimetrically transported to the top of the six-segmented fluid 
bed dryer (six identical dryer cells) through a rotating inlet valve. The filling time per 
cell was 180 seconds, resulting in a cell load of 1 kg granules (based on dry mass) at 
20 kg/h powder feed rate. The inlet air temperature, humidity and airflow rate were 
set at 45°C, 10% and 420 m3/h, respectively. The drying time was fixed at 790 
seconds. At the end of the drying cycle, a rotating discharge valve allowed the 
respective dryer cell to be vacuum discharged followed by one blow back in order to 
clear the corresponding filter. During production, the differential pressure over the 
dryer filters was monitored as an indication for the filter loading. 
 
After drying, the dry granules were pneumatically transported to the granule 
conditioning unit. In this unit, each package of dry granules was milled through a 
Quadro comil U10 (Quadro Engineering, Ontario, Canada), equipped with a 1000µm 
grater screen rotating at 800rpm. The temperature of the mill screen was monitored 
by a Pt100 temperature sensor. After milling, materials were pneumatically 
transported to an in-line conical ribbon blender and blended with 0.58% (w/w) 
magnesium stearate (60rpm for 1 min). The final blend was gravimetrically 
transported to the hopper of a MODULTM P tablet press (GEA Pharma Systems, 
CourtoyTM, Halle, Belgium). The tablet press was equipped with oblong shaped 
concave Euro B punches (15.5 mm x 6.3 mm). Tablets (430 mg) were manufactured 
at a compression force of 12 kN per tablet. 
 
For all runs, milled granules and tablets were sampled every 30 minutes. 
Furthermore, the first filling cycle of the dryer (6 cells) and the last filling cycle of the 
dryer (6 cells) were collected as milled granules and tablets for run 1 and run 2, 
respectively. Samples of milled granules were taken by disconnecting the vacuum 
transfer line between the granule conditioning unit and the in-line lubricant blender at 
predefined time points. Loss on drying (LOD), particle size distribution (PSD), friability, 
bulk and tapped density and Hausner ratio were determined for the milled granules. 
Weight uniformity, hardness, thickness, friability, content uniformity, disintegration 
time, and dissolution of the tablets were tested. Quality attributes of granules and 
tablets produced by the continuous system were compared with granule and tablet 
quality data derived from three batches of the actual batch process (Table 1). 
 
For the continuous process, 100 kg of dry powder blend was processed into 
tablets during 5h production time (i.e. 20 kg/h). Although the actual process time for 
the batch process was similar (about 12h for 240kg), the total time to manufacture the 
tablets via the batch process was much longer compared to the fully continuous from-
powder-to-tablet process due to the lag time and off-line testing between the different 
unit operations of the batch process. Flow diagrams of both production methods are 
shown in Fig. 3. 
 
2.3. Evaluation of granules 
 
2.3.1. Loss on Drying (LOD) 
 Immediately after collection, the residual moisture content of the milled 
granules was determined via loss on drying (LOD) using a Mettler LP16 moisture 
analyser, including an infrared dryer and a Mettler PM460 balance (Mettler-Toledo, 
Zaventem, Belgium). A sample of approximately 9 g was dried at 105°C until the rate 
of change was less than 0.1% LOD for 30 seconds and the % LOD was then 
recorded (n=1). For run 1, LOD measurements of samples taken from the first and 
last filling cycle of the dryer were performed in triplicate. 
 
2.3.2. Particle size analysis 
 
Sieve analysis was performed using a Retsch VE 1000 sieve shaker (Haan, 
Germany). Milled granules were placed on the shaker during 5 min at an amplitude of 
2 mm using a series of sieves (75, 125, 250, 500 and 1000 µm). The amount of 
granules retained on each sieve was determined. All granule batches were measured 
in triplicate. The amount of fines and coarse agglomerates were defined as the 
fractions <75 and >500 µm, respectively. 
 
2.3.3. Friability of granules 
 
The granule friability was determined (n=3) using a friabilator (PTF E Pharma 
Test, Hainburg, Germany) at a speed of 25 rpm for 10 min, by subjecting 10 g (Iwt) of 
milled granules together with 200 glass beads (mean diameter: 4 mm) to falling 
shocks. Prior to determination, the granule fraction <250 µm was removed to assure 
the same starting conditions. Afterwards, the glass beads were removed and the 
weight retained on a 250 µm sieve (Fwt) was determined. The friability was calculated 
as ((Iwt – Fwt) / Iwt)*100. 
 
2.3.4. Flowability 
 
The bulk volume (V0) of 30 g milled granules was recorded in a 100 ml 
measuring cylinder as well as the volume after 1250 taps (V1250) in a tapping machine 
(J. Englesman, Ludwigshafen, Germany) (n=3). Bulk and tapped densities were 
calculated as 30 g / V0 and 30 g / V1250, respectively. The Hausner ratio (HR) was 
calculated from the bulk and tapped density using the following equation, 
Hausner Ratio (HR) = ρf / ρi 
where ρi is the bulk density and ρf is the tapped density [14]. Flow properties were 
described accordingly to the range of Hausner ratio described in USP Powder flow 
<1174> [15]. 
 
2.4. Tablet evaluation 
 
2.4.1. Weight uniformity, hardness and thickness 
 
Weight uniformity was determined after weighing 20 individual tablets of each 
sample taken. The average mass and the amount of tablets deviating by more than 5% 
and 10% from the average mass were calculated. The hardness and thickness of 
tablets (n=10) were determined (Sotax HT 10, Basel, Switserland) after a storage 
period of at least 24 h at 21 °C and 30% RH.  
 
2.4.2. Friability 
 
The tablet friability was determined (n=3) using a friabilator described in Eur. 
Ph. (PTF E Pharma Test, Hainburg, Germany), at a speed of 25 rpm for 4 min. The 
percentage weight loss was expressed as the tablet friability. 
 
2.4.3. Content uniformity, disintegration time and dissolution 
 
To assess the content uniformity, the individual content of the two active 
substances of 10 tablets was determined via HPLC analysis (see section 2.4.4.). The 
disintegration time was determined (n=6) using the apparatus described in Eur. Ph. 
(PTZ-E Pharma Test, Hainburg, Germany). Tests were performed in distilled water at 
37 ± 0.5 °C using disks. Dissolution tests were performed (n=3) in 900 ml 0.1N HCl 
(pH = 1) using the paddle method (VK 7010, Vankel, Cary, NC, USA). The 
temperature of the dissolution medium was maintained at 37 ± 0.5°C, while the 
rotation speed was set at 50 rpm. A 5 ml sample was withdrawn at 30 min after 
starting the dissolution. The content of both drug components was determined via 
HPLC analysis. 
 
2.4.4. HPLC analysis 
 
API concentrations were determined by a validated reversed phase high-
performance liquid chromatography (HPLC)–UV method with gradient. For content 
uniformity analysis, 10 individual tablets per sample were accurately weighed and 
placed into a 50 ml volumetric flask. 30 ml of 20 mM potassium phosphate monobasic 
(PPM) solution was added and mixed for 10 to 15 minutes in order to disintegrate the 
tablets. After the tablets were completely disintegrated, 20 ml of acetonitrile:methanol 
(50/50, v/v) was added. Sample solutions were diluted above to volume with PPM 
solution and mixed. Before filling into the injection vials, the solutions were filtered 
through a 45 µm PFTE filter. 
 The HPLC equipment used for analysis was a Waters 2695 Separations 
Module Alliance system. The Separations Module is an integrated solvent and 
sample management platform (quaternary solvent, high-performance solvent delivery 
system). A PDA detector (λ = 215 nm) (Waters 2996 PDA Detector) was connected to 
the Alliance system and a Supelcosil LC-8-DB column (150 mm x 4.6 mm, 5 µm) was 
used as the silica gel carrier with reversed phase properties. This sorbent was packed 
into a LiChroCart® 125-4 HPLC cartridge (Merck KGaA, Darmstadt, Germany). 
 
3. Results and discussion 
 
3.1. Evaluation of granulation, drying and milling processes 
 
During processing, the ConsiGmaTM-25 system continuously logged 55 
different process parameters/outcomes (1 s interval), supplying a huge amount of 
data. Fig. 4 shows the evolution of four critical process outcomes during the 5h runs: 
the torque on the screws of the granulation unit, the temperature of the water at the 
granulator jacket inlet, the differential pressure over the dryer filters for the dryer 
module and the temperature of the mill screen for the granule conditioning module. 
From these graphs, it is clear that for each parameter a stabilization period was 
needed to reach steady-state conditions. During the initial 30 min of each run, the 
torque increased from 1.5 to 2.0 Nm (Fig. 4a) due to layering of the screws and the 
screw chamber wall with powder material. As the granulation process generates heat 
by friction, the initial layering of the screws and barrel wall with wet mass caused an 
increase of the barrel wall temperature at the work segment of the granulator (from 
25.0°C to 26.0°C). The temperature of the barrel wall was again down regulated to 
the setpoint value (25.0°C) by a feedback control system which compensated by a 
decrease of the water temperature at the granulator jacket inlet (from 26.5 to 21.5°C) 
(Fig. 4b). 
 
During the 5h production runs, a gradual increase of the differential pressure 
over the dryer filters was observed due to increased filter loading with fine particles 
(Fig. 4c). However, the rate of the increase dropped in function of process time: from 
a 15 mbar increase over the 1st hour to 1 mbar during the last hour. By performing a 
19h production run, it was confirmed that after 8h, a plateau phase for this parameter 
was reached (data not shown). A limited increase of the temperature of the mill 
screen was observed during the first part of the process, indicating initial layering of 
the mill screen (Fig. 4d). All process data trends were found to be highly comparable 
between the different runs, indicating the excellent repeatability of the system. 
 
3.2. Evaluation of granule properties 
Different from conventional batch fluid bed drying processes where the drying 
endpoint is mainly determined by temperature-based monitoring methods [16-20], a 
fixed drying time for each cell of the segmented dryer unit was applied in order to 
retain the continuity of the system. LOD values obtained after drying of granules 
produced by the actual batch process were 1.77%, 1.93% and 1.91% for batch 1, 2 
and 3, respectively (Table 1). For the three consecutive continuous runs, the residual 
moisture content of the dried granules was determined in function of process time. All 
LOD values approximated the target LOD value (1.5%) and were in compliance with 
the specifications (1.0-2.0%) of the actual batch process, indicating a stable and 
reliable drying process (Fig. 5). Besides, the drying capacity was clearly not affected 
by the increase of the differential pressure over the dryer filters (Fig. 4c). Although the 
time between the first and the last portion of wet granules entering each cell was 180 
seconds (as filling time per cell was equal to 180 seconds), the standard deviation 
between the different LOD measurements per cell was low (0.01 – 0.08%). 
 
Particle size distributions (PSD) of milled granules were determined. Fig. 6 
shows an overview of the evolution of the amount of material on the different sieves in 
function of process time for run 1. Particle size results were similar over the full length 
of the runs. However, it can be seen from the results of run 1 that slightly deviating 
PSD results were obtained during the first filling cycle of the dryer (Fig. 6). During the 
start-up phase, a lower amount of particles smaller than 250 µm and a higher amount 
of particles larger than 500 µm were produced. The fraction between 250 µm and 500 
µm remained stable. It is suggested that the deviation of PSD observed at start-up 
was due to the initial layering of the grater type mill screen (as can be seen from Fig. 
4d) as a result of which particles encountered more friction yielding a slightly higher 
amount of fines and smaller amount of particles larger than 500 µm. PSD results 
obtained for run 2 and run 3 were similar to the results for run 1 (data not shown). 
 
Fig. 7 shows the PSD results obtained from milled granules produced by the 
continuous twin screw granulation/fluid bed drying process versus the actual batch 
fluid bed granulation/drying process (Table 1, PSD results for batch 1). The 
continuous process resulted in a wider and bimodal PSD, as the PSD consisted of a 
higher amount of fines (F<75 µm) combined with a higher amount of coarse particles 
(F>500 µm), in comparison with the unimodal PSD results for the batch fluid bed 
process. This is in agreement with findings of other researchers who described the 
appearance of bimodal PSD for granules produced by twin screw granulation [8, 10, 
21, 22]. 
 
Results for friability and Hausner ratio of milled granules are shown in Fig. 8. 
For all granules, the friability, an estimate for granule strength, was low (12 to 20%) 
(Fig. 8a). Due to the low friability, downstream processing problems were avoided. 
Again, slightly deviating results were obtained during the start-up phase, as shown by 
the results for run 1. The milled granules obtained during the first filling cycle of the 
dryer had a lower friability, suggesting that the oversized fraction is milled into 
smoother granules when the mill is not yet layered during the initial phase of the 
process. No friability values were recorded for granules produced by the actual batch 
process. 
 
The results for the bulk densities of continuously produced granules ranged 
from 0.508 to 0.545 g/ml, and the tapped densities from 0.612 to 0.652 g/ml. Hausner 
ratio values were calculated from the bulk and tapped densities to describe the 
flowability of the granules. As the Hausner ratios ranged between 1.18 and 1.24, all 
granules could be classified as fair flowing (Fig. 8b). The slightly deviating PSD 
results obtained during the start-up phase of run 1, did not significantly influence the 
flowability of the granules. The bulk densities of the granules produced by the batch 
fluid bed granulation/drying process ranged from 0.420 to 0.523 g/ml, whereas the 
tapped densities ranged from 0.453 to 0.570 g/ml. For the batch process, lower 
Hausner ratios (1.04 to 1.09) were obtained in comparison to the continuous process. 
This can be explained by the higher amount of fine particles (<75 µm) produced by 
the continuous process which negatively influenced the flow properties (Fig. 7). 
Besides, several researchers already described the elongated shape of the granules 
produced by twin scew granulation, while the batch fluid bed process typically 
resulted in the formation of spherical granules [9, 10, 21, 22]. 
 
3.3. Evaluation of tablet properties 
After milling, granules were transferred to an in-line lubricant blender followed 
by the production of tablets. Fig. 9 shows an overview of results for weight uniformity 
and hardness of tablets. Although higher Hausner ratio values were obtained for 
granules produced by the continuous process in comparison with the batch process, 
the weight uniformity of these tablets was excellent (Fig. 9a). Mean weight values 
between 426.1 and 432.3 mg were obtained (maximal RSD-value of 1.12 %RSD for 
all samples) for the continuous process, whereas mean weight values for the batch 
process ranged between 428.0 and 431.8 mg (maximal RSD-value of 0.81 %RSD for 
all samples). Hardness values of tablets produced by the continuous system were 
stable in function of time (Fig. 9b). Mean hardness values ranged from 78.2 to 94.4 N 
and were in compliance with the specifications of the actual batch process (70-110 
N). Mean thickness values (5.25-5.34 mm) were close to the lower acceptance limit of 
the batch process (5.30 mm) in order to obtain conforming hardness values. This 
could be explained by the higher density of the granules produced by twin screw 
granulation and therefore higher resistance to deformation during tableting. Thickness 
values for tablets from the conventional process were also low as mean thickness 
values ranged between 5.32 and 5.37 mm. Compared to the continuously produced 
tablets, mean hardness values of tablets from the batch process were higher (from 
90.4 to 99.6 N). This could be explained by the usage of starch paste as binder 
during the batch fluid bed granulation process, whereas for the continuous process 
water was used as granulation liquid. In this way, continuous manufacturing of starch 
paste could be avoided which decreased the complexity of the continuous process 
from a practical point of view. No deviating results for weight uniformity, hardness and 
thickness were obtained for tablets produced during the start-up and shut down 
phase of the continuous runs (Fig. 9, run 2). 
 
Friability was low for all tablets (0.09-0.20%), allowing subsequent coating. 
Compared to the continuous process, friability was lower for tablets produced by the 
batch process (0.02-0.03%). Again, this could be explained by the usage of starch 
paste as binder during the batch process (see above). 
 Content uniformity of tablets was determined (samples from beginning, middle 
and end of run 2). For the continuous as well as for the batch process, all assay 
results of tablets were within ± 2.5 % of the declared potency (data not shown). Mean 
disintegration times ranged between 123 and 200 seconds and between 176 and 285 
seconds for the continuous and the batch process, respectively (Fig. 10 and Table 1). 
To meet the specifications for dissolution of the actual process not less than 80% of 
the labeled amount should be dissolved after 30 min. From Fig. 11 and Table 1, it is 
clear that the fast disintegration of the tablets produced by both processes resulted in 
a complete release for both APIs after 30 minutes. Similar results for dissolution were 
obtained for the three consecutive continuous runs (data of run 1 and run 3 not 
shown). No deviating results for friability, content uniformity, disintegration time, and 
dissolution were obtained for tablets produced during the start-up and shut down 
phase (Fig. 11). Hence, waste during start-up and shut down was avoided. 
 
4. Conclusions 
 
The results of this study showed a successful process transfer of a 
commercially available product from a batch fluid bed granulation and drying process 
to a continuous twin screw granulation and fluid bed drying process. During three 
consecutive 5h continuous production runs, granule and tablet quality was constant in 
function of time. Although PSD and Hausner ratio values of milled granules were 
found to be different for granules produced by the twin screw granulation process 
compared to the batch fluid bed granulation process, results for critical tablet quality 
attributes were in compliance with the specifications defined for the batch process. 
 
For each of the investigated process outcomes (torque, water temperature at 
the granulator jacket inlet, differential pressure over the dryer filters, temperature mill 
screen) a stabilization period was needed to reach steady-state conditions. However, 
the granules and tablets produced during start-up were in compliance with the 
specifications. No deviant granule and tablet properties were detected at the end of 
each run. Furthermore, process data trends were highly repeatable. Consequently, 
the ConsiGmaTM-25 system can be considered as a stable and repeatable system for 
the continuous production of tablets via wet granulation. 
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Figures 
1 ConsigmaTM-25 continuous tablet manufacturing line: 1. Powder dispensing, 2. 
Screw-based wet granulation module, 3. Segmented fluid bed dryer, 4. Granule 
conditioning unit with 5. Quadro® comil® and 6. Blender (external phase), 7. Blender 
(lubricant), 8. ModulTM P tablet press. 
2 Detail of last part of twin screws. 
3 Process flow diagrams for the actual batch process (left) and the continuous process 
(right). 
4 Evolution of critical process outcomes in function of process time: (a) torque, (b) water 
temperature at the granulator jacket inlet, (c) differential pressure over the dryer filters, 
(d) temperature of mill screen. 
5 LOD results of milled granules in function of process time. 
6 Evolution of particle size distribution of milled granules in function of process time for 
run 1. 
7 Particle size distribution of milled granules produced by continuous twin screw 
granulation/drying versus batch fluid bed granulation/drying. 
8 Granule quality attributes in function of process time: friability (a) and Hausner ratio 
(b). 
9 Tablet quality attributes in function of process time: weight uniformity (a) and 
hardness (b). 
10 Disintegration time of tablets in function of process time. 
11 Percentage drug released after 30 min in function of process time for run 2. 
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Figure 3: Process flow diagrams for the actual batch process (left) and the continuous 
process (right). 
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Tables 
1 Overview of granule and tablet quality attributes derived from the conventional batch 
process: LOD (n=1), PSD (>500µm, 250µm-500µm, 125µm-250µm, 75µm-125µm 
and <75µm) (n=3, mean ± SD), bulk density (n=3, mean ± SD), tapped density (n=3, 
mean ± SD) and Hausner ratio (n=3, mean ± SD) for granules and weight (n=20, 
mean ± SD), hardness (n=12, mean ± SD), thickness (n=12, mean ± SD), friability 
(n=8, mean ± SD), disintegration time (n=8, mean ± SD) and % API 1 and 2 released 
after 30 min dissolution (n=12, mean ± SD) for tablets. 
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Table 1: Overview of granule and tablet quality attributes derived from the conventional 
batch process: LOD (n=1), PSD (>500µm, 250µm-500µm, 125µm-250µm, 75µm-125µm and 
<75µm) (n=3, mean ± SD), bulk density (n=3, mean ± SD), tapped density (n=3, mean ± SD) 
and Hausner ratio (n=3, mean ± SD) for granules and weight (n=20, mean ± SD), hardness 
(n=12, mean ± SD), thickness (n=12, mean ± SD), friability (n=8, mean ± SD), disintegration 
time (n=8, mean ± SD) and % API 1 and 2 released after 30 min dissolution (n=12, mean ± 
SD) for tablets. 
Quality attribute Batch 1 Batch 2 Batch 3 
Granules    
LOD (%) 1.77 1.93 1.91 
> 500µm (%) 6.9 (1.8) 7.7 (0.4) 8.1 (3.8) 
250µm-500µm (%) 42.0 (4.4) 43.6 (1.7) 41.9 (4.9) 
125µm-250µm (%) 38.3 (4.1) 39.4 (2.6) 42.8 (6.3) 
75µm-125µm (%) 8.7 (2.0) 5.9 (2.2) 4.2 (3.4) 
<75µm (%) 4.0 (0.2) 3.5 (1.1) 3.2 ( 0.5) 
Bulk density (g/ml) 0.420 (0.000) 0.460 (0.000) 0.523 (0.006) 
Tapped density (g/ml) 0.453 (0.006) 0.480 (0.000) 0.570 (0.000) 
Hausner ratio 1.08 (0.01) 1.04 (0.00) 1.09 (0.01) 
Tablets    
Weight (mg) (n=20) 428.0 (3.4) 429.5 (2.3) 431.8 (2.5) 
Hardness (N) (n=12) 99.6 (8.4) 98.3 (8.1) 90.4 (7.2) 
Thickness (mm) (n=12) 5.37 (0.03) 5.37 (0.04) 5.32 (0.02) 
Friability (%) (n=8) 0.03 (0.01) 0.02 (0.01) 0.02 (0.01) 
Disintegration time (sec) (n=8) 218 (31) 285 (28) 176 (11) 
% API 1 released after 30 min (n=12) 98.5 (1.0) 99.5 (0.9) 102.5 (0.6) 
% API 2 released after 30 min (n=12) 98.3 (1.3) 99.4 (1.0) 102.0 (0.6) 
 
 
